Diverse Industry Banner


Solutioning the industry with clean data, analysis, and data modernization


Ingenious e-Brain (IeB) stands out by providing comprehensive strategic support to clients throughout the product’s lifecycle—from the preclinical phase to product launch and commercialization. With a track record of 12 years, IeB has been a trusted partner, offering actionable solutions in strategy development, digital innovation and convergence, market transformation, regulatory and competitive intelligence tracking, and commercial analytics. Our strategic planning and analytical insights keep clients informed of the market growth pace & trends and empower them to stay ahead in the competitive landscape.

We offer expertise in healthcare and pharmaceuticals worldwide for all therapeutic areas. Our services encompass several areas, including Competitive Intelligence, Commercial Opportunity Assessment, Disease Landscape and Opportunity Assessment, Evaluation of Patient Journey, Drug Pricing and Market Access, and Brand Strategy.

terend img

1. Competitive Intelligence

IeB provides valuable insights by thoroughly analyzing competitors’ internal processes, strategies, strengths, weaknesses, and market positioning. We conduct market research, benchmarking, and analysis of industry trends to equip clients with the information they need to make informed decisions and stay competitive in their market space.

We go beyond surface-level analysis to comprehensively assess competitors’ strategies and capabilities. Our in-depth analysis covers both approved and pipeline drugs. We offer detailed insights into the market’s competitive intensity and unmet needs by performing pipeline assessment and clinical trial analysis. This is instrumental in formulating current and future strategies, keeping you competitive and up to date with market trends.

4. Disease Landscape Opportunity Assessment

Venturing into a new therapeutic area requires a comprehensive market opportunity assessment and understanding of unmet needs. Thus, we focus on several areas, including disease pathophysiology, epidemiology, market assessment, and stakeholder discussions, to aid in market sizing, identifying gaps in the market, and understanding the key market trends.

IeB supports developing a thorough perspective of different drug development programs, providing data on the current competitive landscape and key focus areas of interest. We identify the key market dynamics, encompassing clinical trial designs of late-stage molecules, and aid clients in various development strategies. Our Disease Landscape Assessment and Situational Analysis provide an overall perspective of the current and futuristic market view for supporting clients in better strategic planning and decision-making. In this, we also cover:

  • Market Sizing and Epidemiology
  • Competitive Landscape Analysis
  • Patient Journey Mapping
  • Treatment Landscape Assessment
  • Strategic Scenario Planning
  • Value Proposition Development
terend img

2. Market Access

In market access, we offer a holistic view of the entire market access ecosystem of the reimbursement and cost-and-coverage dynamics that matter to stakeholders across the value chain. We have worked across diverse therapeutic areas and helped clients navigate the complex healthcare landscape, focusing solely on delivering value. IeB spectrum of services related to market access includes assessing pricing strategies, conducting cost-benefit analysis, analyzing reimbursement scenarios, and using Health Technology Assessments (HTAs) to determine drug pricing based on market conditions, competitor landscape, and payer requirements, ensuring broad patient access.

Through market access, Ingenious e-Brain supports its clients in:

  • Navigating the reimbursement landscape and securing favorable coverage decisions on the formularies from the payers
  • Identifying key stakeholders, such as payers, healthcare providers, and patient advocacy groups, and tailoring value propositions accordingly
  • Engaging with policymakers and advocating for policies that support patient access to innovative therapies
  • Navigating the evolving regulatory landscape and adapting market access strategies

5. Commercial Opportunity Assessment

IeB assists in enhancing pharmaceutical products’ success by anticipating market trends and preparing for challenges. Collaborating with clients, we create compelling business cases and robust forecasting models that consider competitors, adoption rates, and peak market share. Using various techniques, such as analog and attribute analysis, we compare new products to existing ones, factoring in Loss of Exclusivity (LOE) impacts. Sensitivity and scenario analyses identify key success drivers and risks.

  • Our market assessment approach evaluates the competitive landscape, pricing, market size, and growth opportunities, providing detailed comparisons and KPIs.
  • Our deal tracking approach monitors industry partnerships, offering insights and financial modeling to support strategic initiatives.
  • Thorough competitive profiling delivers tailored competitor analysis, utilizing a blend of secondary and primary research.
  • In commercial strategy and business development, we identify and evaluate licensing opportunities, recommend partners, and structure deals to drive growth, helping clients make informed decisions and optimize outcomes.
terend img

3. Support for M&A and Strategic Opportunities

Selecting the appropriate partner for growth and diversification is pivotal. IeB supports clients in this process by identifying suitable companies, initiating exploratory discussions to assess interest in potential collaborations, and facilitating introductions between our client and the prospective partner.

Our industry experts assist corporate development teams by conducting thorough due diligence on potential partners; providing insights into their capabilities, product portfolios, and strategic alignment. Our comprehensive approach includes:

  • Identifying potential partners aligned with clients’ growth objectives
  • Initiating preliminary discussions to gauge interest and feasibility
  • Facilitating introductions to foster meaningful connections
  • Conducting in-depth due diligence to assess partner capabilities and portfolios

Besides this, IeB works closely with clients to pinpoint potential collaborators with complementary synergies and strengths. We identify and evaluate partners with a strategic focus on in-licensing and out-licensing collaborations involving New Chemical Entities (NCEs) and formulations. This collaborative effort aims to uncover fresh market prospects and strategically allocate resources to address portfolio gaps effectively.

6. Product Lifecycle Assessment

Effective Product Lifecycle Management (PLM) is essential for maintaining competitiveness and fostering continuous innovation to secure a company’s market position. At Ingenious e-Brain (IeB), we assist clients in understanding post-commercialization market dynamics and formulating strategies to enhance product profitability. This involves a comprehensive analysis of emerging markets, assessment of potential new indications, and development of strategies to manage Loss of Exclusivity (LOE) to ensure business growth while mitigating the impact of generic drugs.

Our expertise includes:

  • Emerging Market Analysis: Identifying and evaluating growth opportunities in untapped markets.
  • Indication Expansion: Strategically broadening product applications to increase market share.
  • LOE Strategies: Creating robust plans to counteract the effects of patent expiration and generic competition.
  • Profit Optimization: Implementing data-driven approaches to maximize profitability throughout the product lifecycle.
terend img

7. Brand Strategy

The evolution of communication now goes beyond raising awareness about diseases and drugs to actively educating and shaping perceptions about new products. IeB collaborates with clients to recognize target customer segments and craft a unique brand positioning and identity through thorough research. We assist in highlighting essential Unique Selling Points (USPs) and establishing a distinct market presence through a strong brand strategy and communication plan that resonates with key stakeholders, ensuring lasting recall. Additionally, we design campaigns, activities, and promotional messages that are not only measurable but also easily executable.

8. Product Value Proposition

Assessing the viewpoints of Patients, Payers, and Providers plays a fundamental role in defining a distinctive Value Proposition or Target Product Profile (TPP) for a drug during its development phase. By evaluating the patient experience and key stakeholder environment to pinpoint unmet needs, benchmarking competitors’ product attributes, and corroborating with internal preclinical data to establish a value proposition, we can construct scenarios around the TPP. This process enables us to gauge prescriber preferences and anticipate market adoption during the product launch.

9. Real World Evidence Studies

Timely clinical evidence data, which delves into a drug’s utilization, advantages, and potential risks or adverse reactions, is vital for post-market surveillance studies and broadening indications for various diseases or subgroups. Therefore, it is important to analyze real-world data from third-party databases, yielding valuable insights into product efficacy, unmet needs, and the cost-benefit ratio. This is where IeB comes into play.




Suppliers/ Distributors

Product Manufacturers

End User

Provides the payment for the services

Provides reimbursement for the services and products

Influences decision making process

Supplies/distributes ingredients to product manufacturer

Manufactures products for the customers

End users of the products/ services

  • Government
  • Employers
  • Individuals
  • Philanthropy
  • Non-Government Organizations (NGOs/NPOs)
  • Supply/ Demand Analysis
  • Gap Analysis
  • Market Landscaping
  • Technology Transfer
  • Private Insurance Providers
  • Managed Care
  • Consumer Directed Health Plans
  • Pharmacy Benefit Managers (PBMs)
  • Hospital Systems
  • Physicians/Clinics
  • Nursing Homes
  • Home Health
  • Pharmacies
  • Public health
  • Regulatory Assessment
  • Technology Scouting
  • Identifying Cost-efficient Solutions
  • Market Analysis
  • Competitors’ Best Practices
  • Consumer Satisfaction Analysis
  • Technology/Trend Analysis
  • Supplier Analysis and Profiling
  • Competitor Analysis
  • Inventory Management
  • Social media Influencers
  • Key Opinion Leaders (Kols)
  • Medical Researchers
  • Corporates (Healthcare)
  • Media
  • Online Platforms
  • Perception Analysis
  • Sentiment Analysis
  • Goodwill Analysis
  • Influencer Dashboards
  • Consumer Analysis
  • Distributer Analysis
  • Wholesale Distributors
  • Mail-order Distributors
  • Retail Pharmacies
  • Specialty Pharmacies
  • Group Purchasing Organizations
  • Customer/Partner Identification
  • Go-to-market Strategy
  • Competitive Intelligence
  • New Business Models
  • Pharmaceutical/ Biopharmaceutical
  • Medical Devices
  • Capital Equipment
  • Information Systems
  • Contract Research Organization (CRO)
  • Contract Development Manufacturing Organization (CDMO)
  • Technology Scouting
  • R&D/IP Best Practices
  • Consumer Survey
  • Go-to-market Strategy
  • Opportunity Analysis
  • Partner Assessment
  • Competitive Intelligence
  • New Business Models
  • Patients
  • Distributers
  • Stockiest
  • Hospitals
  • Incubators & Innovation Centers
  • service 1
  • service 2
  • service 3
  • service 4
Key Functions
  • CEO & Corporate Strategy
  • CTO & RD&I Leadership
  • BU & Operations Leadership
  • Strategic Leadership
  • Open Innovation, Scouting & M&A Leadership
  • CMO, Marketing Leadership
Client’s Key Business Objective
Support Integration
  • Innovation
  • Competitive
  • Regulatory
  • Strategic
  • Market
  • Sustainable

Client’s Success Story

Client – A leading In-vitro diagnostic manufacturer

Business objective

In-vitro diagnostic manufacturer faces a lot of pricing issues with respect to the product, and due to the competitive pricing of other players and the decisive factor doesn’t lie with the company’s hand

  • The main objective of the engagement was to understand the recent innovations and understand the market scenario and decide the pricing for the product

Key Business Questions

  • What are the newly developed technology and their applications in in-vitro diagnostics
  • Who are the major players and recent innovations in the industry?
  • With recent innovation, how has the price of the product affected?


  • Assessing market scenario. recent product launches, scientific literature, sales figures, product segments,
  • Referred paid databases and identified patents/literature around them.
  • IEBS analyzed the market scenario for the in-vitro diagnostics and developed the pricing model for the client

Business Objective

  • Helped the client comprehend innovations focused on In-Vitro diagnostics
  • Enabled the client to cater to the current innovation in the domain
  • Facilitated the client in understanding on understanding the different pricing and their dependency on the various features
  • Assisted the client in understanding the best price for the product and their dependency on various variables. The team also developed an efficient model for future

In Spotlight - Recent Works

Recent Works

Digital Engineering: Redefining Semiconductors in...

Overview During the last few years, the semiconductor industry encountered a phase of crisis aggravated by a steep decline in PC sales, silicon shortage, geopolitical...

Read More
  • Recent Works

    Smart Pill...

    Business Context  Smart pills, also known as ingestible sensors or digital pills, are ingestible capsules containing miniaturized electronic devices or sensors that diagnose, capture, and...

    Read More
  • Recent Works

    Exploring tech...

    Introduction Geologic hydrogen—also referred to as native, white, or natural hydrogen—is considered a significantly low-carbon and economical fuel. Although geologic hydrogen has not been commercially...

    Read More
  • Recent Works

    Biocon, Biomm:...

    Bengaluru-based biopharmaceutical company Biocon has inked a pact with Brazil-based Biomm SA to commercialize its diabetes treatment in the Latin American nation. As per the...

    Read More



Regional Director

Sacco System
An International Biotech Hub

Ingenious e-Brain has proven to be a true catalyst for our organizational success. Their unparalleled expertise & deep knowledge in the healthcare industry allowed us to reimagine our business model, optimize processes, and enhance customer experiences. Most importantly, we appreciate how they responded promptly and clearly, even during odd hours.


[Chief Quality Officer (CQO)]

Bayer AG
German multinational pharmaceutical and biotechnology company

We have been working with IeB for a long time, and they have been consistently providing deliverables par excellence. We would love to recommend them to our peers for future research & analytics projects. They understood our needs/problems well and worked very patiently and diligently, making changes every time we added new details.


Head of Sustainability Management

Swiss multinational healthcare company

We highly recommend Ingenious e-Brain to anyone seeking innovative solutions in sustainable drug development. Their professionalism, expertise, and dedication have proven invaluable assets to our business, maximizing efficiency & significantly reducing water consumption. Their commitment to sustainable practices has improved our bottom line and aligned our business with our core values.


External Partnering Director

Boehringer Ingelheim
Pharmaceutical company, Germany

I am very impressed with your research and would love to recommend you for future research activities. The team has done a good job of understanding our needs and was very patient in taking care of our needs every time.


Chief Operations Officer (COO)]

Healthcare company, North Carolina

As an established healthcare company in medical, diagnostic, surgical, and analytical lab supplies, broadening our horizons to the regions with potential opportunities has been our key milestone. Thanks to Ingenious e-Brain consultants with high expertise in the healthcare industry for helping us select appropriate regions through market sizing & forecast.

frequently asked questions

We start by benchmarking different technologies and then recommend the ones with great potential. For this, we perform technology scouting to understand what adjacent industries or sectors are using and then assess the feasibility of their implementation. For state-of-the-art technologies, our team develops an understanding of the technology landscape while assessing whitespaces and gaps in the current products and technologies. Other than this, it also involves implementation of various technologies in energy storage sector

Here is what we do to make sure that the specific demands of your customers are being fulfilled:

  • Assessing opportunities by identifying customer needs, industry gaps, tracking new entrants, etc.
  • Understanding regional consumer perspectives through surveys, price sensitivity, new trends, etc.
  • Having a look at the geographical spread of different customer categories, adoption trend in different regions, etc.
  • Identifying new customers and profiling customers based on geographies, revenue potential, buying patterns, etc.
  • Understanding the implementation of various novel materials, processes, and architectures.

To help our clients understand their customers and their opinion, we start by assessing the competitive landscape, positioning, competitions in different regions, etc., followed by analyzing country-wise regulations, government policies, and restrictions and their impact on the business. After that, detailed profiling of companies is done based on SWOT analysis, product portfolio, services, and strategies. When we are able to identify target geographies, adoption trends, and factors affecting business in different geographies, it becomes easier to understand market figures in terms of volume and value, evaluate product segments, etc.

Here are the important things involved in the process:

  • Understanding market figures in terms of volume and value, evaluating product segments, etc.
  • Identifying new customers and profiling customers based on geographies, revenue potential, buying patterns, etc.
  • Assessing competitive landscape, positioning, competitions in different regions, etc.
  • Assessing transforming the industry’s energy savings, reducing emissions, and conserving resources.
  • Identifying improvement towards modularity and the ability to disassemble products, minimizing strong adhesives and blended components.

We help businesses reduce their carbon footprints by CO2 capture and utilization. Our team focuses on several factors such as life cycle assessment, water consumption, energy consumption, etc. and also performs assessments of the techno-commercial aspects of emerging technologies. We implement digitization by identifying competitors best practices, use cases, and business cases. We also encourage the usage of more recycled materials in new products as well as materials which are easier to recycle.

The product development acceleration involves the following things:

  • Assessing the competitive edge and positioning of different players.
  • Estimating the market potential of different product segments.
  • Estimating technology scalability, time to market, risk associated, etc.
  • Assessing opportunities by identifying customer needs, industry gaps, tracking new entrants, etc.
  • Assessing in implementing various products towards high spectral, efficiency, low power consumption, and cost effectiveness.

our Experts